Please assess the completion status of the following clinical trial:

Trial Title: Assessment of a Syringe Pump to Pre-eclamptic Women in a Low-resource Hospital

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Phase 1: Healthy Volunteers~Inclusion Criteria:~* 18 years of age or older~* Provide informed consent~* Agree to comply with study procedures~* Deemed medically stable by their healthcare provider, including normal range blood pressure.~* Have been clinically identified to be able to receive standard IV saline fluid~Exclusion Criteria:~* Women with a history of heart disease of cardiac complications.~* Women with a history of complications with an IV.~Phase 2: Pre-eclamptic Women~Inclusion Criteria:~* 18 years of age or older~* Provide informed consent~* Agree to comply with study procedures~* Have systolic blood pressure P140mm Hg or a diastolic blood pressure P100mm Hg and proteinuria P1+.~* Be pregnant or are \<24 hours postpartum.~* Diagnosed with pre-eclampsia and deemed to benefit from treatment with MGSO4 by healthcare providers~Exclusion Criteria:~* Have systolic blood pressure P140mm Hg or a diastolic blood pressure P100mm Hg and proteinuria P1+.~* Be pregnant or are \<24 hours postpartum.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Healthy Adults (Type: ACTIVE_COMPARATOR): Phase 1 will be an initial validation of the clinical performance of the device delivering only standard IV saline to 10 stable women.
- Pre-eclamptic pregnant women (Type: EXPERIMENTAL): In Phase 2, the device will deliver MgSO4 to up to 40 women presenting with symptoms of pre-eclampsia.

Based on this trial design, predict the completion outcome and termination type (if applicable).